Absorb, the first drug-eluting, fully bioresorbable vascular scaffold , is a new technology for the treatment of coronary artery disease.
http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Cardiovascular-Researchers-At-The-Christ-Hospital-/ArticleNewsFeed/Article/detail/801841?ref=25
http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Cardiovascular-Researchers-At-The-Christ-Hospital-/ArticleNewsFeed/Article/detail/801841?ref=25
No comments:
Post a Comment